BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19398952)

  • 1. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.
    Boehrer S; Adès L; Tajeddine N; Hofmann WK; Kriener S; Bug G; Ottmann OG; Ruthardt M; Galluzzi L; Fouassier C; Tailler M; Olaussen KA; Gardin C; Eclache V; de Botton S; Thepot S; Fenaux P; Kroemer G
    Oncogene; 2009 Jun; 28(22):2205-18. PubMed ID: 19398952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
    Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias.
    Popp HD; Naumann N; Brendel S; Henzler T; Weiss C; Hofmann WK; Fabarius A
    Leuk Res; 2017 Jun; 57():112-118. PubMed ID: 28359030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia.
    Thépot S; Lainey E; Cluzeau T; Sébert M; Leroy C; Adès L; Tailler M; Galluzzi L; Baran-Marszak F; Roudot H; Eclache V; Gardin C; de Botton S; Auberger P; Fenaux P; Kroemer G; Boehrer S
    Cell Cycle; 2011 Jul; 10(14):2323-30. PubMed ID: 21654193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM activation accompanies histone H2AX phosphorylation in A549 cells upon exposure to tobacco smoke.
    Tanaka T; Huang X; Jorgensen E; Gietl D; Traganos F; Darzynkiewicz Z; Albino AP
    BMC Cell Biol; 2007 Jun; 8():26. PubMed ID: 17594478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
    di Masi A; Cilli D; Berardinelli F; Talarico A; Pallavicini I; Pennisi R; Leone S; Antoccia A; Noguera NI; Lo-Coco F; Ascenzi P; Minucci S; Nervi C
    Cell Death Dis; 2016 Jul; 7(7):e2308. PubMed ID: 27468685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways.
    Solier S; Sordet O; Kohn KW; Pommier Y
    Mol Cell Biol; 2009 Jan; 29(1):68-82. PubMed ID: 18955500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes.
    Kefala M; Papageorgiou SG; Kontos CK; Economopoulou P; Tsanas A; Pappa V; Panayiotides IG; Gorgoulis VG; Patsouris E; Foukas PG
    Leuk Res; 2013 Nov; 37(11):1576-82. PubMed ID: 24054861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
    Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
    Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.
    Wetzler M; Kurzrock R; Estrov Z; Estey E; Talpaz M
    Leuk Res; 1995 Jan; 19(1):23-34. PubMed ID: 7837815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage response as a biomarker in treatment of leukemias.
    Halicka HD; Ozkaynak MF; Levendoglu-Tugal O; Sandoval C; Seiter K; Kajstura M; Traganos F; Jayabose S; Darzynkiewicz Z
    Cell Cycle; 2009 Jun; 8(11):1720-4. PubMed ID: 19411853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
    Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.